Clinical Trials in Illinois

Showing 4641-4660 of 19,692 trials

A Real-World Evidence (RWE) Long-Term Follow-Up Study to Assess Outcomes of Alcon Monofocal Intraocular Lenses

NCT05799950

The purpose of this post-market clinical follow-up (PMCF) study is to describe the long-term safety and performance of AcrySof Single-Piece and AcrySof Multi-Piece monofocal intraocular lenses (IOLs).

Aphakia

Alcon Research138 participantsStarted Aug 2023

Burbank, California, United States • Jacksonville, Florida, United States • Rock Island, Illinois, United States +4 more locations

Active Not RecruitingPhase 1/2125 miles

IMGN632 as Monotherapy or With Venetoclax and/or Azacitidine for Participants With CD123-Positive Acute Myeloid Leukemia

NCT04086264

This is an open-label, multicenter, Phase 1b/2 study to determine the safety and tolerability of IMGN632 and assess the antileukemia activity of IMGN632 when administered in combination with azacitidine and/or venetoclax in participants with relapsed and frontline CD123-positive AML.

Acute Myeloid Leukemia

AbbVie218 participantsStarted Nov 2019

Duarte, California, United States • Orange, California, United States • Tampa, Florida, United States +26 more locations

A Real-World Evidence (RWE) Long-Term Follow-Up Study to Assess Outcomes of Alcon Monofocal Intraocular Lenses

IMGN632 as Monotherapy or With Venetoclax and/or Azacitidine for Participants With CD123-Positive Acute Myeloid Leukemia

Find Trials by Condition in Illinois

A Study of Combination Therapy With Venetoclax, Daratumumab and Dexamethasone (With and Without Bortezomib) in Participants With Relapsed or Refractory Multiple Myeloma

A Long-term Follow-up Study of Subjects Who Received CRISPR CAR T Cellular Therapies

Observational Study of HIV+ Deceased Donor Transplant for HIV+ Recipients

Efficacy and Safety of Pemigatinib in Subjects With Advanced/Metastatic or Surgically Unresectable Cholangiocarcinoma Who Failed Previous Therapy - (FIGHT-202)

A Long-Term Follow-Up Observational Study to Evaluate Safety in Subjects Who Have Received a Gene-Modified Regulatory T Cell (Treg) Therapeutic

Study to Evaluate Adverse Events, and Change in Disease Activity, When Intravenously (IV) Infused With Livmoniplimab in Combination With IV Infused Budigalimab in Adult Participants With Hepatocellular Carcinoma (HCC)

Long Term Extension Study of Tapinarof Cream, 1% for Subjects With Atopic Dermatitis

Air Optix Plus HydraGlyde Multifocal Daily/Extended Wear Contact Lenses

Ivosidenib for Patients With Clonal Cytopenia of Undetermined Significance and Mutations in IDH1

A Study of Belzutifan (MK-6482) Plus Pembrolizumab (MK-3475) Versus Placebo Plus Pembrolizumab in Participants With Clear Cell Renal Cell Carcinoma Post Nephrectomy (MK-6482-022)

Surveillance Trial of the Apple Watch in Reliable Burden Assessment in Unseen Recurrence of Surgically Treated AF

A Study to Test Whether Different Doses of BI 1291583 Help People With Bronchiectasis

Evaluation of Non-Invasive Tests for Metabolic Liver Disease

Evaluation of Accuracy of the Owlet OSS 3.0 Sensor in the Neonatal Population

Cessation of Somatostatin Analogues After PRRT in Mid, Hind-Gut and Pancreatic Neuroendocrine Tumours

Post Market Clinical Follow-up (PMCF) Study of Clareon Vivity & Clareon PanOptix

Proton Beam Radiotherapy for Medulloblastoma and Pineoblastoma

Topical ENS-002 for Atopic Dermatitis in Adults